![](https://image.cnbcfm.com/api/v1/image/107363243-1706035367989-gettyimages-1480096596-0j5a5875_rjbkkqvw.jpeg?v=1714559291&w=1920&h=1080)
Johnson & Johnson baby powder is displayed in San Anselmo, California, on April 5, 2023.
Justin Sullivan | Getty Images
Johnson & Johnson on Wednesday said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer.
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
It will begin a three-month voting period for claimants, in hopes of reaching a consensus on a settlement of all current and future ovarian cancer claims. About 99% of the talc-related lawsuits filed against J&J and its subsidiaries stem from ovarian cancer.
J&J said the remaining pending lawsuits relate to a rare cancer called mesothelioma and will be addressed outside of the new settlement plan.
The pharmaceutical giant said it has already resolved 95% of mesothelioma lawsuits filed to date.
This story is developing. Please check back for updates.
Read More: World News | Entertainment News | Celeb News
CNBC